Korea NIH to Use Affymetrix (Bedford, Massachusetts) (AFFX) Technology for Groundbreaking Genome-Wide Association Study  
6/12/2007 1:01:29 PM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that the Republic of Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix Genome-Wide Human SNP Array 5.0 for the Korean Association REsource (KARE) project. This groundbreaking genome-wide association study is designed to identify the genetic causes of lifestyle-related complex diseases that are prevalent in Korea.